The latest headlines across every section, pulled from official and open-access sources.
This cohort study investigates incidence trends of autism spectrum disorder from 2016 to 2024 to quantify the temporal patterns before and after diagnostic substitution and the COVID-19 pandemic.
Prediction market Kalshi launched betting markets tied to clinical trial results and FDA approvals. Healthcare leaders warn the model could invite insider trading and distort the integrity of the research outcomes it’s meant to forecast. The post You Can Now Bet on Clinical Trials Like Playoff Games, But Health Execs Say It Crosses a Line appeared first on MedCity News .
Objective To evaluate the association between use of newer glucagon-like peptide-1 receptor agonists (GLP-1 RAs; semaglutide, tirzepatide) and alcohol-related hospitalisations among adults with alcohol use disorder (AUD) and type 2 diabetes (T2D) or obesity. Retrospective cohort study using target trial emulation. Setting Electronic health record data from a collective of US healthcare systems. Participants Adults with AUD and T2D or obesity who started a newer GLP-1 RA (semaglutide or tirzepatide) or a relevant active comparator between 1 January 2018 and 31 December 2024. Interventions…
Rep. Angie Craig introduced a bill to establish a public health insurance option on the ACA marketplaces and permanently extend enhanced premium tax credits. The post New Bill Seeks to Create Public Option on ACA Marketplaces appeared first on MedCity News .
Philips said its updated device provides accurate readings across a range of skin tones, following concerns that pulse oximeters can be less accurate in people with darker skin pigmentation.
Agios Pharmaceuticals said tebapivat fell short of expectations in a Phase 2 test in sickle cell disease. It’s the latest in a series of disappointing industry developments in sickle cell disease. The post Agios Pharma Drops Sickle Cell Disease Drug After Phase 2 Data Disappoint appeared first on MedCity News .
The deadline for submitting new resolutions to be heard at the spring 2027 Board of Governors meeting is Sept. 18, 2026.
The UK government has worked with the NHS, the government of the Democratic Republic of the Congo (DRC) and international health partners to medically evacuate a humanitarian worker who has been treating patients with Ebola in the DRC.
FDA created the Rare Disease Innovation Hub (the Hub) to serve as a point of collaboration and connectivity between CBER and CDER with the goal of ultimately improving outcomes for patients.
A rare disease startup with a mission to repurpose proven drugs has licensed a Chinese formulation of a well-known medicine and set its sights on a $50 million fundraise.
July 21st, 2026, PT Organics Limited of Lake Oswego, Oregon is voluntarily recalling select Pumpkin Tree Peter Rabbit Organics Banana & Strawberry 4 oz. (113 g) pouches because of an internal packaging defect that may result in the presence of a strand of soft, food-grade plastic in the finished pro
South Asians (SA) in the United States carry a higher burden of atherosclerotic cardiovascular disease (ASCVD) than other ethnic groups, and standard risk prediction tools often fail to capture this elevated risk.
A group of 61 biopharma companies, executives and investors has filed an amicus brief in support of the FDA in an ongoing case brought by Louisiana meant to remove access to the abortion pill mifepristone.
Influenza vaccines marketed in the UK for 2026 to 2027, including ovalbumin content.
How to label, package and submit specimens to the laboratory for diagnostic testing.
A guide to UKHSA's bacteriology reference department (BRD), its units and the tests and services it provides.
The computing platform will make its debut at the Society of Robotic Surgery meeting this week, as Medtronic challenges Intuitive in the U.S. robotic soft tissue market.
Crystalys Therapeutics has raised $130 million in series B financing to advance the development of its gout drug dotinurad and prepare for a potential commercial launch.
by Chuang Liang, Godfrey Pearlson, Juan Bustillo, Peter Kochunov, Jiayu Chen, Xiangrong Zhang, Rongtao Jiang, Kent E. Hutchison, Jing Sui, Zening Fu, Xiao Yang, Yuhui Du, Daoqiang Zhang, Shile Qi, Vince D. Calhoun Background The difference between neuroimaging-predicted brain age and chronological age, the predicted age difference (PAD), has been studied as a potential biomarker reflecting individual brain health. Although previous large-scale studies have shown that brain age deviations occur across multiple disorders, cross-disorder comparisons of PAD within a unified framework, together…
by Casey Crump, Jingkai Wei, Jan Sundquist, Kristina Sundquist Background Women with adverse pregnancy outcomes have higher subsequent cardiovascular risks, but their long-term risks of peripheral artery disease (PAD) and potential causality are unclear. A better understanding of such risks is needed to improve early risk stratification, clinical care, and long-term cardiovascular health. We sought to determine long-term risks of PAD associated with 5 major adverse pregnancy outcomes in a large population-based cohort, and to assess for familial confounding using co-sibling analyses. Methods…
by Lise Jamieson, Leigh F. Johnson, Jeffrey W. Imai-Eaton, Hasina Subedar, Linda-Gail Bekker, Gesine Meyer-Rath Background South Africa accounts for 20% of global HIV infections. Six-monthly injectable lenacapavir (LEN) for HIV pre-exposure prophylaxis (PrEP) has superior efficacy to oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC), and similar efficacy to 2-monthly injectable cabotegravir (CAB). With LEN’s regulatory approval, South Africa faces critical implementation decisions amid constrained domestic resources and reduced international funding. We evaluated the epidemiological…
Screening for mental health symptoms in patients with significant allergic disease is not overreach The post How Diagnostic Precision in Allergy Care Supports Mental Well-Being appeared first on MedCity News .
Information on how to stay safe in hot weather, including how to keep your home cool.
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction. The post Why Pharma Companies Should Look To Social Media For Better Patient Insight appeared first on MedCity News .